glp-1 news october 16 2025 Market Trends and Global Forecasts Report 2025: A As GLP-1 Drugs Go Mainstream,

GLP-1 produces a direct suppression of POMC neurons in the appetite control center of the brain, leading to suppression of appetite

Currently, Ozempic remains solely FDA-approved for Type 2 Diabetes, while Wegovy is FDA-approved for chronic weight management

It typically subsides within minutes

MET: metformin

Patients Who Stalled on Dual Agonists: Individuals who reached a plateau on a dual agonist despite optimal dosing may benefit from the added energy-expenditure and appetite-modulating effects of the third pathway

A reverse image search shows that the image being used as the account's profile photo is actually a stock photo image from iStock titled "blonde woman doctor in office"